IL-10はスフィンゴリピドの代謝を抑制して炎症を抑制する

Autumn G York^1,2,3, Mathias H Skadow⁴, Joonseok Oh^5,6

¹Department of Immunobiology, Yale University, New Haven, CT, USA. AGYork@UW.edu.

Nature

|February 21, 2024

まとめ

インタールイキン10 (IL-10) 欠乏症は,非常に長い鎖のセラミドの増加による炎症を引き起こします. 脂肪酸の合成を復元することで炎症性疾患の代謝修正を強調します

科学分野:

免疫学
代謝経路
細胞生物学

背景:

インタールイウキン10 (IL-10) は重要な抗炎症サイトカインです.
IL-10の信号の喪失は炎症性腸疾患のような重症な炎症状態につながります
IL - 10が炎症を抑制する正確なメカニズムは完全に理解されていません.

研究の目的:

IL-10の抗炎症機能の基礎にある分子メカニズムを解明する.
IL-10欠乏による炎症における非常に長い鎖のセラミド (VLC) の役割を調査する.
代謝経路を標的とした治療戦略を探求する.

主な方法:

IL-10欠乏したモデルでの遺伝子発現を調査した.
VLCのセラミド生成を抑制するためにセラミド合成酵素2 (Cers2) の遺伝子消去を活用した.
モノ不飽和脂肪酸の合成経路を操作した
転写因子RELの活動を評価した.

主要な成果:

IL-10欠乏症における炎症性遺伝子発現の増加は,飽和したVLCセラミドの増加と関連しています.
Cers2の遺伝的消去または脂肪酸合成の回復は,IL-10欠乏したモデルにおける炎症を減少させた.
VLCセラミドによる炎症は,持続的なREL活動に依存する.
IL-10シグナリングは,VLCセラミド代謝に影響を与える脂肪酸不飽和プログラムを調節する.

結論:

IL-10シグナリングは脂肪酸代謝を調節し,VLCセラミドの蓄積を防ぐことで炎症を制御する.
異常なVLCセラミド代謝とREL活性化は,IL-10欠乏症の病理に寄与する.
VLCホメオスタシスの代謝的修正は,IL-10に関連する炎症性疾患に対する潜在的な治療方法を示しています.

さらに関連する動画

07:54

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Published on: September 2, 2014

47.0K

12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

3.4K

関連する概念動画

01:24

T Cell Types and Functions

1.0K

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

1.0K

01:28

Inflammatory Response

2.0K

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

2.0K

01:20

The JAK-STAT Signaling Pathway

8.9K

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

8.9K

01:11

IP3/DAG Signaling Pathway

12.1K

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...

12.1K

01:16

TGF - β Signaling Pathway

7.4K

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Inflammation